Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial

BACKGROUND: Major protease mutations are rarely observed following failure with protease inhibitors (PI), and other viral determinants of failure to PI are poorly understood. We therefore characterized Gag-Protease phenotypic susceptibility in subtype A and D viruses circulating in East Africa follo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sutherland, Katherine A., Parry, Chris M., McCormick, Adele, Kapaata, Anne, Lyagoba, Fred, Kaleebu, Pontiano, Gilks, Charles F., Goodall, Ruth, Spyer, Moira, Kityo, Cissy, Pillay, Deenan, Gupta, Ravindra K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575205/
https://www.ncbi.nlm.nih.gov/pubmed/26382239
http://dx.doi.org/10.1371/journal.pone.0137834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575205/
https://www.ncbi.nlm.nih.gov/pubmed/26382239
http://dx.doi.org/10.1371/journal.pone.0137834

Ejemplares similares